Viva Biotech Holdings (HKSE:01873) Share Price

Company Profile

Business description
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
Contact
735 Ziping Road
Pudong New District
Zhoupu Town
Shanghai201318
CHN
T: +86 2160893288
https://www.vivabiotech.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
2,063

Recommended

This Australian success story looks set to face profit margin compression from the scariest of competitors.

Johannes Faul, CFA | 11 August 2025

For individual investors, it is important to frame earnings season revelations in a long-term way.

Joseph Taylor | 11 August 2025

Shares soared 30% in the last week but are still undervalued.

Shane Ponraj, CFA | 11 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,150.30	32.70	0.36%
CAC 40	7,706.62	8.10	0.11%
DAX 40	23,994.16	87.18	-0.36%
Dow JONES (US)	43,975.09	200.52	-0.45%
FTSE 100	9,156.10	26.39	0.29%
HKSE	24,969.68	62.87	0.25%
NASDAQ	21,385.40	64.62	-0.30%
Nikkei 225	42,718.17	897.69	2.15%
NZX 50 Index	12,759.68	152.18	-1.18%
S&P 500	6,373.45	16.00	-0.25%
S&P/ASX 200	8,880.80	36.00	0.41%
SSE Composite Index	3,665.92	18.37	0.50%